I'm glad leronlimab doesn't have the problem bamla
Post# of 148190
3. 6:06 We believe leronlimab is not dependent on whether the virus is the wild-type virus or a variant. Our target is not the virus... Our goal is to restore immune function in the sickest Covid19 patients.
34. 35:15 We do not need separate trials for the variants. Leronlimab will not be affected by the variants because of the target. That is our advantage.
Read More: https://investorshangout.com/post/view?id=6093110